TrialClinical pharmacology in drug development2026

A Phase 1, Randomized, Placebo-Controlled, Multiple-Dose, Double-Blind Study to Evaluate and Compare the Pharmacokinetics and Safety of Rimegepant in Healthy Adult Japanese and Caucasian Individuals.

Rajinder Bhardwaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.